Bausch Health Companies Inc. (BHC): Shareholders' Equity
$377.00M
As of 2025-12-31
-$802.00M
As of 2026-06-30
+13.2%
3-year compound annual growth
-9.0%
5-year compound annual growth
-24.2%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $377.00M | n/m | 2026-02-19, Balance as of period end |
| 2024-12-31 | -$322.00M | n/m | 2026-02-19, Balance as of period end |
| 2023-12-31 | -$82.00M | n/m | 2026-02-19, Balance as of period end |
| 2022-12-31 | $260.00M | n/m | 2025-02-20, Balance as of period end |
| 2021-12-31 | -$34.00M | n/m | 2024-02-22, Balance as of period end |
| 2020-12-31 | $605.00M | -46.7% | 2023-02-23, Balance as of period end |
| 2019-12-31 | $1.14B | -59.6% | 2022-02-23, Balance as of period end |
| 2018-12-31 | $2.81B | -52.6% | 2021-02-24, Balance as of period end |
| 2017-12-31 | $5.94B | +82.4% | 2020-02-19, Balance as of period end |
| 2016-12-31 | $3.26B | -46.0% | 2019-02-20, Balance as of period end |
| 2015-12-31 | $6.03B | +11.6% | 2018-02-28, Balance as of period end |
| 2014-12-31 | $5.40B | +3.2% | 2017-03-01, Balance as of period end |
| 2013-12-31 | $5.23B | +40.8% | 2016-04-29, Balance as of period end |
| 2012-12-31 | $3.72B | -7.2% | 2014-02-28, Balance as of period end |
| 2011-12-31 | $4.01B | -18.4% | 2012-02-29, Balance as of period end |
| 2010-12-31 | $4.91B | +262.6% | 2012-02-29, Balance as of period end |
| 2009-12-31 | $1.35B | +12.7% | 2012-02-29, Balance as of period end |
| 2008-12-31 | $1.20B | n/a | 2011-02-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $377.00M | n/m |
| Zoetis Inc. (ZTS) | 2025-12-31 | $3.33B | -30.2% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $18.67B | +13.7% |
| Viatris Inc (VTRS) | 2025-12-31 | $14.71B | -21.1% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $31.26B | +6.5% |
| Organon & Co. (OGN) | 2025-12-31 | $752.00M | +59.3% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $7.91B | +47.1% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.36B | +30.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.55B | +7.4% |
Compare BHC, ZTS, VRTX, VTRS side by side · Screen every company in Pharmaceutical Preparations ↗